Add To Watchlist
Share URL
About The Company
CEO
Dr. Reginald Seeto M.D., MBBS
Market Cap
391.45 Million USD
Sector
Healthcare
Website
https://www.caredx.comLast Update
2/22/2024, 12:00:00 PM
Description
CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide.
Read More
Overview
Value
4
Growth
2
Health
43
Management
46
Analyst Opinion
46
Total
27
All Scores Out Of 100
Best Features
- Has a low level of debt
- Low preportion of income is paid as dividend
Risk Factors
- Overvalued on cashflow basis
- Earnings have declined recently
- Income is not covering expenditure and investment
- Earnings are negative
- There is a history of diluting shareholders
- Altman-Z score suggests a risk of bankruptcy
- No margin of safety at their current market price
- Disliked by Twitter users
- Poor earnings and cashflow growth
- Accounting anomalies: Growing revenues without a corresponding growth in cash flows.
- Dividend could be at risk
Market Peers
CDNA
Key Figures
PE Ratio (TTM)
N/A
Margin Of Safety (DCF)
-70.05%
Revenue Growth (5 Year Average)
7.31%
Ratings Consensus
Sell
Share Buybacks
-2.60%
Dividend Yeild (TTM)
0.00%
Valuation
Value Score
4
Desired Margin Of Safety
0%
▼
Tip: Set your desired Margin Of Safety
Free Cash Flow Type
Annual Cashflow Growth
0%
Discount Rate
0%
Buy Target: < 4.3 USD ✘
Current Price: 11.4 USD
Negative Cashflows: Cashflow can become negative due to operating losses, investing activities or financing activites. Negative cashflow makes it dificult to use a discounted free cashflow model to assess intrinsic value.
How Does This Work?
Show Advanced Options
This calculator helps investors estimate the Intrinsic Value of a company based on the current value of future cash flows. To use the tool, simply input a desired Margin Of Safety, which is an additional discount applied to the present value of the expected future cash flows. The tool calculates the present value using a discount rate that reflects the risk and time value of money, and provides an estimated target price for the company based on the selected margin of safety. The calculator defaults to using 5 Year Free Cash Flow Growth % and a discount rate based on the US 10-year treasury bond coupon rate. Use our performance analyser to get a feel the impact this has on longterm investment returns and discover a margin of safety you are comfortable with. This can be a useful tool for investors looking to make informed decisions about whether to buy or sell shares of a particular company.
Price/Earnings
N/Ax
Free Cashflow Yeild
-4.70%
PE/Earnings Growth
N/A
Price/Book
2.25x
Growth
Growth Score
2
- ✔ Free Cashflow growth has improved this year
- ✘ 5 Year Average Revenue growth of 7.31% is lower than the market average (10.97%)
- ✘ Revenue growth has slowed this year
- ✘ 5 Year Average Earnings growth of -13.34% is lower than the market average (14.48%)
- ✘ Earnings growth has slowed this year
- ✘ 5 Year Average Free Cashflow growth of -17.90% is lower than the market average (12.35%)
Revenue Growth
7.31%
Earnings Growth
-13.34%
Cashflow Growth
-17.90%
Health
Health Score
43
Altman Z Score
0.14
Piostroski Score
3.00
Debt/Equity
0.13x
Current Assets/Liabilities
4.02x
Free Cashflow/Total Debt
0.00x
Debt/Capital
0.11x
Dividend
Secure Dividend Score
0
- ✔ Long term dividend payout ratio of -24.84% is considered good
- ✔ Payout ratio (TTM) of 0.00% is lower than the average (40%)
- ✔ Dividends have shown growth over the last 5 years
- ✘ Dividend yeild of 0.00% is less than the market average (1.85%)
- ✘ Very unsafe
- ✘ Spending a higher percentage of their income on dividends than last 5 years
Dividend Yeild
0.00%
Dividend Growth
0.00%
Payout Ratio (Earnings)
0.00%
Payout Ratio (Cashflow)
0.00%
Management
Management Score
46
Average Buybacks/Dilution
-2.60%
Recent Buybacks/Dilution
-3.02%
5 Year Price Volitility
67.56%
Return On Assets
-23.61%
Return On Capital Employed
-3.18%
Return On Equity
-43.79%
Return On Free Cashflow
N/A
Return On Investments
-74.40%
Analysts
Analyst Opinion
46
- ✘ Ratings consensus is Sell
SEC Filings
Find yearly (10-K), quaterly (10-Q) and disclosure (8-K) report here, on the Securities and Exchange Commission's EDGAR database. If reading through reports isn't your cup of tea, don't worry. We've made it easy for you by summarizing all the important bits.
Other Information
Company Name
CareDx, Inc
Currency
USD
Beta
0.995901
Vol Avg
902642
Ceo
Dr. Reginald Seeto M.D., MBBS
Cik
0001217234
Cusip
14167L103
Exchange
NASDAQ Global Market
Full Time Employees
727
Industry
Diagnostics & Research
Sector
Healthcare
Ipo Date
2014-07-17
Address
1 Tower Place
City
South San Francisco
State
CA
Country
US
Zip
94080
Phone
415 287 2300
Analysis Last Updated
2/22/2024, 12:00:00 PM
All financial data provided by FMP
Social Sentiment
Social Sentiment Score
23
Twitter Sentiment
0.00
Stocktwits Sentiment
46.00